Litcius/Paper detail

Retinol dehydrogenase 10 reduction mediated retinol metabolism disorder promotes diabetic cardiomyopathy in male mice

Yandi Wu, Tongsheng Huang, Xinghui Li, Conghui Shen, Honglin Ren, Haiping Wang, Teng Wu, Xinlu Fu, Shijie Deng, Zi-qi Feng, Shijie Xiong, Hui Li, Saifei Gao, Zhenyu Yang, Fei Gao, Lele Dong, Jianding Cheng, Weibin Cai

2023Nature Communications57 citationsDOIOpen Access PDF

Abstract

Diabetic cardiomyopathy is a primary myocardial injury induced by diabetes with complex pathogenesis. In this study, we identify disordered cardiac retinol metabolism in type 2 diabetic male mice and patients characterized by retinol overload, all-trans retinoic acid deficiency. By supplementing type 2 diabetic male mice with retinol or all-trans retinoic acid, we demonstrate that both cardiac retinol overload and all-trans retinoic acid deficiency promote diabetic cardiomyopathy. Mechanistically, by constructing cardiomyocyte-specific conditional retinol dehydrogenase 10-knockout male mice and overexpressing retinol dehydrogenase 10 in male type 2 diabetic mice via adeno-associated virus, we verify that the reduction in cardiac retinol dehydrogenase 10 is the initiating factor for cardiac retinol metabolism disorder and results in diabetic cardiomyopathy through lipotoxicity and ferroptosis. Therefore, we suggest that the reduction of cardiac retinol dehydrogenase 10 and its mediated disorder of cardiac retinol metabolism is a new mechanism underlying diabetic cardiomyopathy.

Topics & Concepts

RetinolInternal medicineEndocrinologyRetinoic acidCardiomyopathyDiabetic cardiomyopathyLipotoxicityDiabetes mellitusMedicineBiologyVitaminHeart failureBiochemistryInsulin resistanceGeneRetinoids in leukemia and cellular processesRetinal Diseases and TreatmentsEndoplasmic Reticulum Stress and Disease
Retinol dehydrogenase 10 reduction mediated retinol metabolism disorder promotes diabetic cardiomyopathy in male mice | Litcius